Glenn Crater

Also affiliated with Inversago Pharma (Canada)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial”.

Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(25)00216-5

N/A

0.433DataRank · unranked

10 citations

George Kunos, Dror Dicker, Jean‐Sébastien Paquette, Louis J. Aronne, Ofir Frenkel +5 more